Yang, Hung-Chih <br/><br/>
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.  [electronic resource] 

 -  Journal of hepatology  08 2018 
 - 286-292 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0641 
<br/><br/><label>Standard No.: </label>10.1016/j.jhep.2018.02.033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Biomarkers--blood<br/>DNA, Viral--blood<br/>Female<br/>Hepatitis B--complications<br/>Hepatitis B Antibodies--blood<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B virus--physiology<br/>Humans<br/>Lymphoma, Non-Hodgkin--complications<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Risk Assessment--methods<br/>Rituximab--therapeutic use<br/>Taiwan<br/>Virus Activation--immunology